July 29, 2016
Recommended Topic Related To:


"FDA is recommending health care professionals discontinue prescribing and dispensing prescription combination drug products that contain more than 325 milligrams (mg) of acetaminophen per tablet, capsule or other dosage unit. There are no"...



Discontinued Warning IconPlease Note: This Brand Name drug is no longer available in the US.
(Generic versions may still be available.)

Provisc Side Effects Center

Medical Editor: John P. Cunha, DO, FACOEP

Last reviewed on RxList 3/21/2016

Provisc (1% sodium hyaluronate) is an ophthalmic surgical aid used in the anterior segment during cataract extraction and intraocular lens (IOL) implantation. The brand name Provisc is discontinued, but generic versions may be available. Common side effects of Provisc include:

  • a temporary rise in intraocular (eye) pressure
  • post-operative inflammation, and
  • eye swelling.

Dosing of Provisc is determined by a physician. Provisc may interact with other drugs. Tell your doctor all medications and supplements you use. Tell your doctor if you are pregnant before receiving Provisc. Consult your doctor before breastfeeding.

Our Provisc (1% sodium hyaluronate) Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

What is Prescribing information?

The FDA package insert formatted in easy-to-find categories for health professionals and clinicians.

Provisc FDA Prescribing Information: Side Effects
(Adverse Reactions)


PROVISC (sodium hyaluronate) Viscoelastic Preparation is extremely well-tolerated after injection into human eyes during ophthalmic surgical procedures. As with most viscoelastic ophthalmic preparations, a transient rise in intraocular pressure has been reported in some cases.

Postoperative inflammatory reactions such as hypopyon and iritis have been reported with the use of ophthalmic viscoelastic preparations, as well as incidents of corneal edema and corneal decompensation. Their relationship to the use of sodium hyaluronate (PROVISC (sodium hyaluronate) ) has not been established.

Read the entire FDA prescribing information for Provisc (Sodium Hyaluronate)

Report Problems to the Food and Drug Administration


You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

Women's Health

Find out what women really need.